> Investors > Investor Relations Home

Investor Relations Home

Corporate Profile

ACETO Corporation, incorporated in 1947, is a global leader in the marketing, sale and distribution of products for Human Health (finished dosage form generics and nutraceutical products), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products). With business operations in nine countries, ACETO distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. ACETO’s global operations, inc... More >>

Recent News

More >>
04/03/14
ACETO Subsidiary, Rising Pharmaceuticals, Launches the Authorized Generic of Validus' Lotensin HCT(R)
03/27/14
ACETO Corporation to Acquire 100% of the Equity Interests of PACK Pharmaceuticals, LLC
02/26/14
ACETO Appoints Carlos Restrepo to Lead Performance Chemicals

Recent & Upcoming Events

More >>
Q2 2014 Aceto Earnings Conference Call
Friday, February 7, 2014 9:00 a.m. ET
Aceto at Piper Jaffray Healthcare Conference
Tuesday, December 3, 2013 10:30 a.m. ET
Aceto at Deutsche Bank dbAccess Small and Mid Cap Conference
Wednesday, November 20, 2013
Q1 2014 Aceto Earnings Conference Call
Friday, November 8, 2013 9:00 a.m. ET
Aceto Q4 2013 Earnings Conference Call
Thursday, August 29, 2013 9:00 a.m. ET
Aceto at Jefferies Global Healthcare Conference
Wednesday, June 5, 2013 4:00 p.m. ET
Aceto Q3 2013 Earnings Conference Call
Friday, May 10, 2013 9:00 a.m. ET
Aceto Q2 2013 Earnings Conference Call
Friday, February 8, 2013 9:00 a.m. ET

Stock Information

ExchangeNASDAQ (US Dollar)
Price$21.60
Change (%) Stock is Down 0.17 (0.78%)
Intraday High$21.90
Intraday Low$21.50
Volume269,197
Minimum 20 minute delay Refresh quote
Stock chart for: 03NA000000ACET

Investor Contact

Jody Burfening
Investor Relations
LHA
800 Third Avenue
New York, NY 10022
Phone: 212.838.3777
Fax: 212.838.4568
E-mail: JBurfening@lhai.com


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

top